| Literature DB >> 15073289 |
David Ezra1, Uvidelio F Castillo, Gary A Strobel, Wilford M Hess, Heidi Porter, James B Jensen, Margaret A M Condron, David B Teplow, Joseph Sears, Michelle Maranta, Michelle Hunter, Barbara Weber, Debbie Yaver.
Abstract
Coronamycin is a complex of novel peptide antibiotics with activity against pythiaceous fungi and the human fungal pathogen Cryptococcus neoformans. It is also active against the malarial parasite, Plasmodium falciparum, with an IC(50) of 9.0 ng ml(-1). Coronamycin is produced by a verticillate Streptomyces sp. isolated as an endophyte from an epiphytic vine, Monstera sp., found in the Manu region of the upper Amazon of Peru. Bioassay-guided fractionation of the fermentation broths of this endophyte on silica gel and HPLC chromatography yielded two principal, inseparable, peptides with masses of 1217.9 and 1203.8 Da. Three other minor, but related components, are also present in the preparation. Amino acid analysis of coronamycin revealed residues of component 1, component 2, methionine, tyrosine and leucine at a ratio of 2:2:1:1:3. Other compounds with antifungal activities are also produced by this endophytic streptomycete.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15073289 DOI: 10.1099/mic.0.26645-0
Source DB: PubMed Journal: Microbiology ISSN: 1350-0872 Impact factor: 2.777